Zydus Lifesciences Limited has informed the Exchange regarding a press release dated August 09, 2024, titled "Press Release".
Press Release Aug 09 2024
Filed with NSE ·
6ix hasn’t read this filing yet.
Zydus Lifesciences Limited on 6ix
In the deck
Earlier from Zydus Lifesciences
- Press Release Jul 31 2024
- Press Release Jul 23 2024
- Press Release Jul 22 2024
- Press Release Jul 19 2024
- Press Release Jul 17 2024
Later from Zydus Lifesciences
- Press Release Aug 23 2024
- Press Release Aug 27 2024
- Press Release Aug 30 2024
- Zydus receives final approval from USFDA for Scopolamine Transdermal System 1 mg/3 days
- Press Release Sep 10 2024
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences